Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

EHA 2019 | MRD by flow cytometry

Giuseppe Gaipa • 15 Jun 2019
EHA 2019
General Leukemia

Giuseppe Gaipa, PhD, M. Tettamanti Research Center, Pediatric Clinic University of Milano Bicocca, Monza, Italy, discusses the use of MRD by flow cytometry to measure the individual response of each patient to treatment. Speaking at the 24th Congress of the European Hematology Association (EHA) 2019, held in Amsterdam, Netherlands, Prof. Gaipa also mentions the need for increased technique sensitivity to help meet the clinical needs of patients.

More from Giuseppe Gaipa

1:29
EuroFlow MRD measurement
Giuseppe Gaipa • 15 Jun 2019
5:35
Advanced flow cytometry & CAR-T for the treatment of acute leukemias
Giuseppe Gaipa • 15 Jun 2019

Related Videos

2:06
Managing relapsed ALL: the role of novel cellular therapies & importance of conditioning regimens
Christina Peters • 15 Apr 2024
4:07
Pooled fecal allogeneic microbiotherapy to treat refractory gastrointestinal acute GvHD
Florent Malard • 11 Apr 2024
5:23
Current and emerging treatment approaches for steroid-refractory acute & chronic GvHD
Mohamad Mohty • 17 Apr 2024
2:00
HHV-6 reactivation after haploidentical transplantation with PTCy & ATG: incidence and risk factors
Rémy Duléry • 15 Apr 2024
The content of VJHemOnc is intended for healthcare professionals